Amplia

Be first to know our latest company updates

Watch exclusive videos accompanying major news

Science

Contact

Board

Company Overview

Team

Corporate Governance

Corporate Directory

Values

Clinical Advisers

About Us

Video Updates

Presentations

In the News

Communication

Updates

US Shareholders

Investor FAQs

Shareholder Services

Research Reports

Reports

Announcements

Investor Fact Sheet

Top 20 Shareholders

Share Price

Investor Centre

Clinical Trial

Webinars

Home

Montserrat

Amplia Therapeutics Limited

Amplia Therapeutics has today announced that Mr Tim Luscombe will replace Mr Hamish George as Chief Financial Officer (CFO) of the Company. 
 
Mr Luscombe is a highly experienced Chartered Accountant who holds a Bachelor of Commerce from the University of Melbourne and a Certificate in Governance Practice from the Governance Institute of Australia. He is a Director at Bio101 Financial Advisory and has been working with Amplia in a senior accounting capacity over the last two years. 
 
Amplia’s CEO and Managing Director, Dr Chris Burns, commented:  
 
“We are delighted that Tim is taking on the role of CFO at Amplia. His knowledge of the company and close working relationship with the team means it will be a seamless transition. We would also like to thank Hamish for his excellent work over the previous years.”

Click link below to read the full ASX Release.

Amplia appoints new CFO